• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Lymphoblastic Lymphoma

Lymphoblastic Lymphoma - 24 Studies Found

Completed : Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma
: Lymphoma, Lymphoblastic
: 2015-03-18
:
  • Drug: induction

Completed : BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma
:
  • T-Acute Lymphoblastic Leukemia
  • Adult T Lymphoblastic Lymphoma : 2016-05-03
    :
    • Drug: BL-8040
    • Drug: Nelarabine

Terminated : A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
:
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma

: 2014-09-22
: Drug: pegcrisantaspase
Active, not recruiting : Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
:
  • Lymphoblastic Leukemia, Acute T-cell
  • Precursor T-Cell Lymphoblastic Ly
    : 2011-04-22
    :
    • Drug: BMS-906024 Other Name: N

Completed : Hyper-CVAD Plus Nelarabine in Untreated T-ALL/Lymphoblastic Lymphoma
:
  • Leukemia
  • Lymphoblastic Lymphoma
  • Drug: Doxorubicin

Completed : LBL-2016 for Children or Adolescents in China
: Lymphoblastic Lymphoma
: 2016-07-24
:
  • Drug: Prednisone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosp

Completed : Treatment of Relapsed T-Cell Acute Lymphoblastic Leukemia or T-Lymphoblastic Lymphoma With MabCampath
:
  • Adult Acute Lymphocytic Leukemia T-Cell
  • Lymphoma, Lymphoblastic
    : 2005-09-12
    :
    • Drug: Alemtuzumab (MabCampath)
    • Drug: Cladr

Recruiting : Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
:
  • Leukemia
  • Precursor-B Acute Lymphoblastic Leukemia
  • : 2015-04-14
    :
    • Drug: Cytarabine

Not yet recruiting : Study of Clofarabine, Etoposide, Cyclophosphamide [CEC], Liposomal Vincristine (VCR), Dexamethasone and Bortezomib in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LL)
:
  • Hematopoietic/Lymphoid Cancer
  • Acute Lymphoblastic Leukemia
  • : 2017-04-27
    :
    • Drug: Clofarabine

Withdrawn : An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase)
:
: 2025-08-02
<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.